Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
about
A Review of Imaging Methods for Prostate Cancer Detection.Update on positron emission tomography for imaging of prostate cancerPositron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitationsComparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-cholinePositron emission tomography in uro-oncology.Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancerPET/CT Imaging and Radioimmunotherapy of Prostate CancerMolecular imaging of prostate cancer: PET radiotracers.PET/CT in prostate cancer: non-choline radiopharmaceuticals.Imaging localized prostate cancer: current approaches and new developments.(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland.Translational Molecular Imaging of Prostate Cancer.Novel tracers and their development for the imaging of metastatic prostate cancer.Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.FDG PET in Prostate Cancer.PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Imaging and evaluation of patients with high-risk prostate cancer.PET imaging for lymph node dissection in prostate cancer.Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer.FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.Clinical implications of PET/CT in prostate cancer management
P2860
Q26766398-08027273-32D5-40DB-9A21-83E06C9BB275Q27026828-712ADBFF-80E9-4211-B26B-1AB553AD5DD0Q33625371-559F3AB0-DCDB-4E60-827D-276C45E5E9E8Q34035683-29948E0F-0D39-4890-B027-4BAC609F7E53Q34228828-5EC5F7DF-54C5-4E6E-911B-67F2ABB8738CQ34448553-53467447-3111-40DF-BB94-659AA83572ADQ35172954-DA7F6D66-324C-465F-ADBC-6149F16E50FEQ36033412-1BD92F7C-A9FF-43E7-993D-66B0E813F696Q36085426-A0347D2D-5310-433E-A80A-9F280AF17E52Q36129937-FDA14B18-D159-48CE-9EE6-44C3AAD2521CQ36308766-4563D831-3800-43FE-8CFD-1A6FAA1F7D8DQ36469177-A5F827F5-8F32-4763-9D98-65562E01A176Q36502692-BB640463-2E63-49B4-A4D5-395811406F4FQ37085677-0FB1C7B4-05E0-4870-A56B-B31E633FAAB4Q37244969-D7825D80-737D-4DFD-BB89-8BD730C92B3CQ37321810-ADE80C38-9BDA-41FC-9904-918EF9CB02C5Q37325974-2C618A40-4B20-4267-92F5-38B6CF249E40Q37352995-E909BF19-135A-41C5-9967-74BFDF04EEF3Q37390670-E1F9E2B6-39F0-4BA5-AE37-DA60FD1781EBQ38190115-47A5082C-255D-4ECB-BC2A-235CCCDE8D7DQ38321182-813853BC-2921-4434-A295-794BC6606AD8Q38611187-3496C370-0980-49AD-AD99-682C55787023Q38983526-24C5B0D9-9C95-4CAC-8411-38B1EB63108DQ39143177-1D48C2AD-FD41-4C3C-954F-5F585C65C972Q40448619-E5DEAA23-3513-4456-B5EA-357562B49734Q42117913-12088876-215A-4614-A124-3C4B54F9FC04Q42137476-3897E7D6-3808-42AA-B323-7D259258E239Q53060499-D9230C7F-07B4-43FC-8DE1-823458BC047AQ59137133-90C34B93-0B73-4143-A761-D98093FAA2D0
P2860
Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@en
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@nl
type
label
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@en
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@nl
prefLabel
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@en
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@nl
P2093
P356
P1476
Detecting metastatic pelvic ly ...... for localized prostate cancer.
@en
P2093
Albert Kao
Chao-Hsiang Chang
His-Chin Wu
Jeffery J P Tsai
Sheng-Pin Changlai
Yeh-You Shen
P304
P356
10.1159/000070141
P577
2003-01-01T00:00:00Z